A pilot study of high‐dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0–N3M0 squamous cell carcinoma of the upper aerodigestive tract
Robert L. Foote(Mayo Clinic), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Paul D. Brown(Mayo Clinic), Jan L. Kasperbauer(Mayo Clinic), Yolanda I. Garces(Mayo Clinic), Douglas A. Nichols(Sapienza University of Rome), Scott H. Okuno(Mayo Clinic), Kerry D. Olsen(Mayo Clinic), Daniel J. Sargent(National Institute of Agricultural Botany)
Cited by 34
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k